# The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia

> **NCT07230171** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 92 (estimated)

## Conditions studied

- Fibromyalgia
- Pregabalin
- Esketamine

## Interventions

- **DRUG:** Pregabalin and venlafaxine concomitant therapy
- **DRUG:** Esketamine plus pregabalin and venlafaxine concomitant therapy

## Key facts

- **NCT ID:** NCT07230171
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-08-31
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230171, "The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07230171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*